LP Area »
Home
About Us
Our Team
Portfolio Companies
News
Contact Us
Venture
Subscribe
In the News
VIRENT DELIVERS TEST VOLUMES OF BIOJET FUEL TO US AIR FORCE LAB
Wednesday, May 1st, 2013
|
Clean Tech
NANOBIO’S NOVEL NANOSTAT TECHNOLOGY DEMONSTRATES SIGNIFICANT EFFECTIVENESS AS INTRAMUSCULAR VACCINE ADJUVANT
Tuesday, April 23rd, 2013
|
Healthcare
NETSOCKET SECURES $9.2M SERIES B ROUND OF FUNDING
Tuesday, April 2nd, 2013
|
Technology
CHROMATIN ADDS ROBERT B. SHAPIRO TO BOARD OF DIRECTORS
Thursday, March 28th, 2013
|
Clean Tech
INVIRAGEN: COLORADO BIOTECH’S LATEST MILESTONES EXEMPLIFY BIG-PICTURE PROGRESS TOWARD A DENGUE VACCINE
Thursday, March 21st, 2013
|
Healthcare
ALFALIGHT SELLS COMMERCIAL COMPONENT PRODUCT LINE TO COMPOUND PHOTONICS; HIGH EFFICIENCY AND WAVELENGTH STABILIZED LASER TECHNOLOGY IS KEY
Saturday, March 16th, 2013
|
Technology
VIRENT: BIOFUEL FIRM QUICKLY MOVING FORWARD
Friday, March 15th, 2013
|
Clean Tech
CELLERATION REACHES KEY MILESTONE OF 1 MILLION MIST THERAPY TREATMENTS
Wednesday, March 13th, 2013
|
Healthcare
CHROMATIN SIGNS PACT WITH POET TO USE SOUTH DAKOTA-GROWN SORGHUM IN ETHANOL PRODUCTION
Monday, March 11th, 2013
|
Clean Tech
RESHAPE MEDICAL COMPLETES ENROLLMENT OF PIVOTAL CLINICAL TRIAL FOR WEIGHT LOSS DEVICE
Friday, March 8th, 2013
|
Healthcare
INVIRAGEN BEGINS SECOND STAGE OF PHASE II STUDY OF DENGUE VACCINE, DENVAX
Friday, March 1st, 2013
|
Healthcare
NON-SURGICAL WEIGHT LOSS DEVICES – AN INTERVIEW WITH RICHARD THOMPSON, CEO, RESHAPE MEDICAL
Friday, March 1st, 2013
|
Healthcare
CHROMATIN SIGNS SORGHUM SUPPLY DEAL WITH AEMETIS
Friday, February 22nd, 2013
|
Clean Tech
NEUROVANCE RECEIVES NOTICE OF ALLOWANCE FOR COMPOSITION OF MATTER PATENT AND INITIATES CLINICAL TRIAL OF NEW SR FORMULATION OF EB-1020
Thursday, February 21st, 2013
|
Healthcare
CHROMATIN AND PACIFIC ETHANOL SIGN MULTI-YEAR AGREEMENT FOR LOCALLY-GROWN SORGHUM IN ETHANOL PRODUCTION
Monday, February 18th, 2013
|
Clean Tech
CHROMATIN’S DIRECTOR OF FIELD OPERATIONS, LARRY MCDOWELL, BECOMES PRESIDENT OF TEXAS SEED TRADE ASSOCIATION
Monday, February 4th, 2013
|
Clean Tech
JUVENTAS THERAPEUTICS, INC. HIRES BIOTECHNOLOGY VETERAN PAUL RESNICK AS VICE PRESIDENT OF BUSINESS DEVELOPMENT
Wednesday, January 30th, 2013
|
Healthcare
CHROMATIN TO HOST MODESTO, CALIFORNIA GROWER MEETING TO DISCUSS GRAIN SORGHUM PRODUCTION OPPORTUNITIES FOR ETHANOL
Monday, January 21st, 2013
|
Clean Tech
TISSUE REGENERATION SYSTEMS: GROWTH FACTOR-UM SPINOFF AIMS TO USE MESH TO CREATE BONE
Sunday, January 20th, 2013
|
Healthcare
WOUND-HEALING FIRM CELLERATION CLOSING IN ON $7M ROUND OF FUNDING
Monday, January 14th, 2013
|
Healthcare
CHROMATIN: SORGHUM U WILL HIGHLIGHT PROFITABILITY, WATER MANAGEMENT
Thursday, December 27th, 2012
|
Clean Tech
CHLOROFILL AND CHROMATIN PARTNER TO HARVEST SORGHUM BIOMASS FOR THE PRODUCTION OF RENEWABLE BUILDING MATERIALS
Saturday, December 15th, 2012
|
Clean Tech
CHROMATIN: GRAIN SORGHUM WELL RECEIVED IN CALIFORNIA TRIAL
Friday, December 7th, 2012
|
Clean Tech
NANOBIO SEALS $11M SERIES C
Thursday, November 29th, 2012
|
Healthcare
INVIRAGEN AND THE INTERNATIONAL VACCINE INSTITUTE EXPAND PARTNERSBHIP
Thursday, November 8th, 2012
|
Healthcare
NOVELOS THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN BRAIN CANCER TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER
Thursday, October 25th, 2012
|
Healthcare
NEUROVANCE: CAMBRIDGE BIOTECH SPINOFF RAISES $7M FOR NEW ATTENTION DEFICIT DRUG
Thursday, October 18th, 2012
|
Healthcare
EUTHYMICS COMPLETES ENROLLMENT IN TRIADE, ITS ADVANCED TRIAL OF AMITIFADINE FOR MAJOR DEPRESSIVE DISORDER
Thursday, October 11th, 2012
|
Healthcare
NANOBIO PROMOTES DAVID PERALTA TO CHIEF EXECUTIVE OFFICER
Tuesday, October 9th, 2012
|
Healthcare
AERPIO COMES TO THE “RESCUE” WITH HPTP-BETA DRUG FOR DME
Friday, October 5th, 2012
|
Healthcare
NOVELOS BRINGING LIGHT TO THE DARKNESS FOR CANCER VICTIMS
Tuesday, September 25th, 2012
|
Healthcare
NEUWAVE MEDICAL RAISES $14M IN VENTURE FUNDING
Thursday, September 6th, 2012
|
Healthcare
PROCERTUS BIOPHARM TACKLES THE UNPLEASANT SIDE EFFECTS OF CANCER TREATMENT
Saturday, September 1st, 2012
|
Healthcare
PROCERTUS BIOPHARM TACKLES THE UNPLEASANT SIDE EFFECTS OF CANCER TREATMENT
Saturday, September 1st, 2012
|
Healthcare
AERPIO THERAPEUTICS COMPLETES $27M SERIES A FINANCING
Thursday, August 30th, 2012
|
Healthcare
NOVELOS THERAPEUTICS DEVELOPING CLR1502 (GLOW2) CANCER-TARGETED OPTICAL IMAGING AGENT FOR INTRAOPERATIVE TUMOR MARGIN ILLUMINATION
Tuesday, August 28th, 2012
|
Healthcare
JUVENTAS: DRUG BUOYS CLEVELAND COMPANY’S STEM-CELL ASPIRATION
Monday, August 27th, 2012
|
Healthcare
JUVENTAS THERAPEUTICS DOSES FIRST PATIENT IN PHASE II STOP-HF TRIAL
Monday, August 20th, 2012
|
Healthcare
VMWARE SNACKS ON PATTERN INSIGHT’S LOG TOOL
Thursday, August 9th, 2012
|
Technology
JUVENTAS THERAPEUTICS RAISES $22.2 MILLION SERIES B FINANCING
Monday, July 16th, 2012
|
Healthcare
NOVELOS DOSES THREE PATIENTS IN PHASE 1/2 PET IMAGING TRIAL FOR METASTATIC BRAIN CANCER
Thursday, June 21st, 2012
|
Healthcare
NOVELOS: POSITIVE INITIAL IMAGING RESULTS FROM LIGHT PHASE I/II TRIAL OBSERVED
Tuesday, June 19th, 2012
|
Healthcare
NOVELOS THERAPEUTICS ANNOUNCES POSITIVE INITIAL IMAGING RESULTS IN BRAIN CANCER TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER
Tuesday, June 19th, 2012
|
Healthcare
VIRENT WELCOMES JOHN RICE TO BOARD
Monday, May 21st, 2012
|
Clean Tech
CELLERATION, INC. ANNOUNCES FIRST PATIENT ENROLLMENT IN IN-BALANCE VLU RANDOMIZED CONTROL TRIAL
Monday, May 14th, 2012
|
Healthcare
AERPIO APPOINTS DR. ADRIENNE GRAVES TO BOARD OF DIRECTORS
Thursday, May 10th, 2012
|
Healthcare
2012 INNOVATION AWARDS: EMERGING INNOVATION WINNER AKEBIA
Friday, April 20th, 2012
|
Healthcare
AERPIO ANNOUNCES POSITIVE PHASE 1 DATA ON FIRST-IN-CLASS TIE2 ACTIVATOR, AKB-9778, IN DEVELOPMENT FOR DIABETIC MACULAR EDEMA
Friday, April 20th, 2012
|
Healthcare
VIRENT: WANT TO CUT RELIANCE ON FOREIGN OIL? REPLACE THE WHOLE BARREL
Wednesday, April 18th, 2012
|
Clean Tech
PATTERN INSIGHT LAUNCHES BETA VERSION OF ITS IT ANALYTICS SOLUTION FOR BIG DATA
Tuesday, April 10th, 2012
|
Technology
AKEBIA MEETS PRIMARY ENDPOINT IN PHASE 2 STUDY OF ONCE-DAILY, ORAL ANEMIA TREATMENT, AKB-6548
Thursday, April 5th, 2012
|
Healthcare
VIRENT BIOJET FROM VIRDIA CELLULOSIC SUGARS PASSES RIGOROUS TESTS
Monday, March 26th, 2012
|
Clean Tech
EUTHYMICS BIOSCIENCE, INC. INITIATES CLINICAL TRIAL FOR NEW DRUG TARGETED FOR ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Thursday, March 22nd, 2012
|
Healthcare
VENTURE MI II INVESTS $15M IN WISCONSIN EARLY-STAGE FUND
Monday, March 19th, 2012
|
Venture Investors
INVIRAGEN HAND, FOOT AND MOUTH DISEASE VACCINE GENERATES IMMUNE RESPONSE IN 100% OF STUDY PARTICIPANTS
Monday, March 12th, 2012
|
Healthcare
ROCKWELL AUTOMATION ACQUIRES SOFTSWITCHING TECHNOLOGIES, A LEADING PROVIDER OF INDUSTRIAL POWER QUALITY DETECTION AND PROTECTION SYSTEMS
Monday, March 12th, 2012
|
Clean Tech
CAN VIRENT’S TECHNOLOGY MOVE FROM THE LAB TO THE GAS PUMP?
Wednesday, March 7th, 2012
|
Clean Tech
NOVELOS THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN LUNG CANCER TRIAL WITH I-124-CLR1404 (LIGHT) CANCER-TARGETED PET IMAGING AGENT AT UW CARBONE CANCER CENTER
Wednesday, February 22nd, 2012
|
Healthcare
VIRENT CEO LEE EDWARDS PROMOTES BENEFITS OF ADVANCED BIOFUELS FOR FARMERS BEFORE SENATE AGRICULTURE COMMITTEE
Wednesday, February 15th, 2012
|
Clean Tech
VIRENT BOARD OF DIRECTORS WELCOMES NEW MEMBER
Wednesday, January 18th, 2012
|
Clean Tech
NOVELOS THERAPEUTICS ENROLLS FIRST PATIENT IN PHASE 1B TRIAL IN SOLID TUMORS WITH (131)I-CLR1404 (HOT) CANCER-TARGETED MOLECULAR RADIOTHERAPEUTIC
Wednesday, January 18th, 2012
|
Healthcare
NEW COMPANY, AERPIO THERAPEUTICS, CREATED TO ADVANCE NOVEL TIE-2 ACTIVATORS AND HIF-1A STABILIZERS FOR MULTIPLE DISEASES
Monday, January 9th, 2012
|
Healthcare
VIRENT ANNOUNCES ISSUANCE OF FIVE US PATENTS COVERING ITS BIOFORMING TECHNOLOGY
Friday, January 6th, 2012
|
Clean Tech
CHROMATIN, INC. AWARDED $5.7 MILLION FROM THE DOE TO DEVELOP DROP-IN BIOFUELS
Wednesday, January 4th, 2012
|
Clean Tech
CHROMATIN AWARDED $5.7M FROM US DOE TO DEVELOP DROP-IN BIOFUELS
Wednesday, January 4th, 2012
|
Clean Tech
VIRENT AND THE COCA-COLA COMPANY SIGN AGREEMENTS TO DEVELOP AND SUPPLY 100% RENEWABLE, RECYCLABLE PLANTBOTTLE™
Thursday, December 15th, 2011
|
Clean Tech
HOW VIRENT IS USING PLANTS TO REPLACE OIL
Thursday, December 15th, 2011
|
Clean Tech
INVIRAGEN: VACCINES IN DEVELOPMENT TO PROTECT AGAINST DENGUE FEVER
Tuesday, December 13th, 2011
|
Healthcare
INVIRAGEN HIRES NEW MEDICAL OFFICER
Tuesday, December 13th, 2011
|
Healthcare
CHROMATIN, INC. PASSES MAJOR MILESTONE IN SWEET SORGHUM TECHNOLOGIES
Tuesday, December 13th, 2011
|
Clean Tech
INVIRAGEN: VACCINES IN DEVELOPMENT TO PROTECH AGAINST DENGUE FEVER
Tuesday, December 13th, 2011
|
Healthcare
NANOBIO SIGNS PRECLINICAL COLLABORATION PACT WITH MERCK FOR RSV VACCINE
Monday, December 12th, 2011
|
Healthcare
INVIRAGEN PRESENTS SAFETY AND IMMUNE RESPONSE DATA FROM A PHASE 1 STUDY OF ITS TWO-DOSE DENGUE VACCINE, DENVAX
Wednesday, December 7th, 2011
|
Healthcare
EUTHYMICS BIOSCIENCE SHOWS PROMISE WITH ADHD DRUG
Wednesday, December 7th, 2011
|
Healthcare
EUTHYMICS: BALANCING ACT
Monday, December 5th, 2011
|
Healthcare
« Previous Entries
Categories
Clean Tech
Healthcare
Technology
Venture Investors
Archive
2013
2012
2011
2010
2009
2008
Search